Direct-acting antivirals still underused in hep C-related liver cancer
by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M
Updated on: April 10,2024
12
Direct-acting antivirals still underused in hep C-related liver cancer
by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M
Updated on:April 10,2024
12